AVBP vs BWA · $1.39B cap vs P/E 41, rev $7.18B
ArriVent BioPharma, Inc. Common Stock (AVBP) versus BorgWarner Inc (BWA) — a side-by-side from cached financials, not a winner call.
ArriVent BioPharma, Inc. Common Stock (AVBP) is a biotechnology company listed on US.
BorgWarner Inc (BWA) is a auto parts company listed on NYSE.
AVBP does not have a complete income-statement cache yet.
Latest reported BWA revenue for 2026-06-30 was $7.18B. Net income was $519.0M. BWA currently screens at market cap $14.47B and trailing P/E 41.0.
AVBP currently screens at market cap $1.39B. BWA currently screens at market cap $14.47B and trailing P/E 41.0.
Not investment advice. Open the AVBP and BWA stock pages for the full models.
Not investment advice.